chartexchange

RCEL
Avita Medical, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:59 PM EST
16.80USD+6.531%(+1.03)716,045
Pre-marketNov 18, 2026 8:59:30 AM EST
15.68USD-0.571%(-0.09)
After-hoursNov 18, 2026 4:21:30 PM EST
16.78USD-0.119%(-0.02)
Loading…
Loading…
532.35M
Healthcare
Medical Devices
HQ
Valencia, CA, USA
Previous Close
$15.77
Beta
1.61
52-Week High
$18.43 2026-11-09
52-Week Low
$3.22 2026-01-07
SMA 50
$13.59
SMA 200
$7.27
Avg. Vol 10D
709,762
Avg. Vol 30D
522,990
Avg. Vol 90D
476,466
Relative Vol
1.37
23.89M
2.6200%
8,933
Jun 30, 2020 · 1-for-5 (reverse)
RCEL Profile

avita medical (http://www.avitamedical.com/) is a publicly listed regenerative medicine company trading on the australian stock exchange (asx:avh) and otc markets (otcqx:avmxy). the company's lead product, recell® is used in a wide variety of burns, chronic wounds, plastic, reconstructive and cosmetic procedures. recell is patented, ce-marked for europe, tga- registered in australia, and sfda-cleared in china. recell is not available for sale in the united states; in the us recell is an investigational device limited by federal law to investigational use.

RCEL Performance
PeriodPriceDateChangeBeta
1W17.302026-11-11-2.89%-1.985
1M13.142026-10-19+27.85%1.553
3M9.852026-08-18+70.56%1.716
6M4.192026-05-18+300.95%1.494
1Y3.952025-11-18+325.32%1.613
2Y12.432024-11-18+35.16%—
5Y15.402021-11-18+9.09%1.427
RCEL Stock Summary

Avita Medical, Inc. Common Stock (NASDAQ:RCEL) stock price today is $16.80, and today's volume is 716,045. RCEL is up 6.531% today. The 30 day average volume is 522,990. RCEL market cap is $532.35M with 31.69M shares outstanding.